SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001239916-03-000003
Filing Date
2003-11-20
Accepted
2003-11-20 15:09:55
Documents
1
Period of Report
2003-11-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT c0001239916d20031120f3f.html 3  
1 PRIMARY DOCUMENT c0001239916d20031120f3f.xml 3 1290
  Complete submission text file 0001239916-03-000003.txt   2884
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 PINE STREET PHILADELPHIA PA 19106
Business Address
UPRICHARD DAVID C (Reporting) CIK: 0001239916 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23736 | Film No.: 031015418